Benchling’s unicorn status didn’t come overnight. Some 10 years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The ...
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...
SAN FRANCISCO, June 11, 2025 /PRNewswire/ -- Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a software framework that helps ...
SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...
Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run "Most R&D systems can't represent the antibody formats teams are actually working with," said ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results